Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
OtherClinical Investigations (Human)

Recovery of decreased metabotropic glutamate receptor 5 availability in abstinent alcohol-dependent patients

Jenny Ceccarini, Gil Leurquin-Sterk, Cleo Crunelle, Bart de Laat, Guy Bormans, Hendrik Peuskens and Koen Van Laere
Journal of Nuclear Medicine September 2019, jnumed.119.228825; DOI: https://doi.org/10.2967/jnumed.119.228825
Jenny Ceccarini
1 Department of Imaging and Pathology, KU Leuven, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gil Leurquin-Sterk
1 Department of Imaging and Pathology, KU Leuven, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Cleo Crunelle
2 Toxicological Center, University of Antwerp; Department of Psychiatry, University Hospital Brussels, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bart de Laat
1 Department of Imaging and Pathology, KU Leuven, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guy Bormans
3 Laboratory for Radiopharmacy, KU Leuven, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hendrik Peuskens
4 University Psychiatric Center, KU Leuven, Kortenberg; Kliniek Broeders Alexianen, Belgium;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Koen Van Laere
5 Nuclear Medicine & Molecular Imaging, UZ Leuven; Department of Imaging and Pathology, KU Leuven
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF
Loading

Abstract

Animal models of alcohol dependence and relapse demonstrate an important role of the glutamatergic system, in particular the cerebral metabotropic glutamate receptor 5 (mGluR5). Using [18F]FPEB positron emission tomography, it was found that chronic alcohol use leads to decreased limbic mGluR5 availability, where lower mGluR5 was associated with less craving. Here, we tested whether the state of decreased mGluR5 availability in alcohol-dependent patients normalizes during abstinence (at 2- and 6-month of detoxification) and whether initial mGluR5 imaging parameters can predict individual relapse. Methods: [18F]FPEB scans were performed in 16 recently detoxified alcohol-dependent patients (baseline condition), after 2 months (n = 10) and 6 months (n = 8) of detoxification, in comparison to 32 age- and gender-matched controls. mGluR5 availability was quantified by [18F]FPEB total distribution volume using both voxel-by-voxel and volume-of-interest analysis. During follow-up, craving was assessed using the Desire for Alcohol Questionnaire, and alcohol consumption was assessed by a Time-Line Follow Back and monitored by hair ethyl glucuronide analysis. Results: During abstinence, alcohol-dependent patients showed a sustained recovered mGluR5 availability in cortical and subcortical regions (pheight<0.001) compared to baseline, up to the levels observed in controls after 6 months in most areas except for the hippocampus, nucleus accumbens and thalamus. A higher striato-pallidal mGlu5 availability was observed at baseline in patients who relapsed during the 6-month follow-up period (+25.1%). Also, normalization of striatal mGlu5 to control levels was associated with reduced craving (“Desire and intention to drink” and “Negative reinforcement”, range r = 0.72-0.94). Conclusion: Reduced cerebral mGluR5 availability in alcohol-dependent patients recovers during abstinence, and is associated with reduced craving. Higher striatal mGluR5 availability in alcohol-dependent users may be associated with long-term relapse.

  • Molecular Imaging
  • Neurology
  • PET/CT
  • abstinence
  • alcohol addiction
  • craving
  • mGlu5
  • Copyright © 2019 by the Society of Nuclear Medicine and Molecular Imaging, Inc.
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine: 66 (5)
Journal of Nuclear Medicine
Vol. 66, Issue 5
May 1, 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Recovery of decreased metabotropic glutamate receptor 5 availability in abstinent alcohol-dependent patients
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Recovery of decreased metabotropic glutamate receptor 5 availability in abstinent alcohol-dependent patients
Jenny Ceccarini, Gil Leurquin-Sterk, Cleo Crunelle, Bart de Laat, Guy Bormans, Hendrik Peuskens, Koen Van Laere
Journal of Nuclear Medicine Sep 2019, jnumed.119.228825; DOI: 10.2967/jnumed.119.228825

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Recovery of decreased metabotropic glutamate receptor 5 availability in abstinent alcohol-dependent patients
Jenny Ceccarini, Gil Leurquin-Sterk, Cleo Crunelle, Bart de Laat, Guy Bormans, Hendrik Peuskens, Koen Van Laere
Journal of Nuclear Medicine Sep 2019, jnumed.119.228825; DOI: 10.2967/jnumed.119.228825
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Supplemental
  • Info & Metrics
  • PDF

Related Articles

  • This Month in JNM
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Clinical Investigations (Human)

  • The added value of 18F-FDG PET/CT compared to 68Ga-PSMA PET/CT in patients with castration-resistant prostate cancer
Show more Clinical Investigations (Human)

Clinical (Neurology)

  • Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT
  • Postinfectious Neurologic Complications in COVID-19: A Complex Case Report
Show more Clinical (Neurology)

Similar Articles

Keywords

  • Molecular imaging
  • Neurology
  • PET/CT
  • abstinence
  • alcohol addiction
  • craving
  • mGlu5
SNMMI

© 2025 SNMMI

Powered by HighWire